Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 981 of 5804
-
Mind over menopause: brain training trial targets hot flashes and mood
Symptom relief Recruiting nowThe goal of this study is to evaluate a neuroplasticity-based mind-body intervention, Amygdala and Insula Retraining (AIR), compared to a wait-list control in individuals experiencing perimenopausal symptoms. Our research questions include: Does AIR reduce overall perimenopausa…
Phase: NA • Sponsor: Chronic Conditions Research Fund • Aim: Symptom relief
Last updated Jul 01, 2026 00:00 UTC
-
New drug XYA02 takes on tough cancers in first human trial
Disease control Not yet recruitingThis study will evaluate the safety, tolerability, and efficacy of XYA02 in participants with advanced solid tumors.
Phase: PHASE1, PHASE2 • Sponsor: XYone Therapeutics, Inc • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
Can a painkiller blocker boost cancer immunotherapy?
Disease control Not yet recruitingThis Phase 2, open-label, multicenter study will evaluate the safety and preliminary efficacy of axelopran in combination with pembrolizumab in patients with PD-L1 positive recurrent or metastatic head and neck squamous cell carcinoma (R/M HNSCC). Axelopran is a peripherally acti…
Phase: PHASE1, PHASE2 • Sponsor: Glycyx Therapeutics • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
Could a light cap save infant brains after cardiac arrest?
Disease control Not yet recruitingApproximately 15,200 children receive cardiopulmonary resuscitation (CPR) for in-hospital cardiac arrest (IHCA) each year in the United States. Of these, about 60% are less than one year of age. Most IHCA (85-90%) occurs in intensive care units (ICU) or other monitored settings. …
Phase: NA • Sponsor: Mitovation, Inc • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
Shorter radiation after thymic tumor surgery may cut side effects
Disease control Recruiting nowThis is a prospective, open-label, single-arm Phase II study designed to evaluate the safety of postoperative hypofractionated radiotherapy in patients with Stage II/III thymic epithelial tumors after complete resection. After a screening period of up to 28 days, eligible patient…
Phase: PHASE2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Could fewer antibiotics be better for older women with urinary symptoms?
Diagnosis Not yet recruitingThis project aims to improve the diagnosis and management of urinary tract symptoms in older women by comparing three common treatment strategies-empiric antibiotics, urinalysis-guided therapy, and culture-directed care-in a randomized trial. By integrating patient-reported outco…
Phase: PHASE3 • Sponsor: Megan Bradley • Aim: Diagnosis
Last updated Jul 09, 2026 00:00 UTC
-
Gene therapy trial hopes to ease hemophilia a
Disease control Recruiting nowThis study will assess the safety and tolerability of SPK-8011QQ in adult males with moderately severe to severe hemophilia A.
Phase: PHASE1, PHASE2 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
Vacuum bandage may shield ECMO patients from wound infections
Prevention Not yet recruitingPatients undergoing extracorporeal membrane oxygenation (ECMO) are at increased risk of wound complications at the vascular access site after decannulation. These complications may delay recovery and increase healthcare burden. Closed incision negative pressure wound therapy (NPW…
Phase: NA • Sponsor: St. Antonius Hospital • Aim: Prevention
Last updated Jul 18, 2026 00:00 UTC
-
Could a vaccine shield HIV-Exposed newborns? early trial launches
⭐️ VACCINE ⭐️ Not yet recruitingThe purpose of this study is to evaluate the safety and immunogenicity of 426c.Mod.Core-C4b vaccine adjuvanted with 3M-052-AF + Alum in infants with perinatal HIV exposure who are without HIV at birth
Phase: PHASE1 • Sponsor: HIV Vaccine Trials Network • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 08:03 UTC
-
Metformin may stop severe pregnancy sickness before it starts
Prevention Recruiting nowThe goal of this clinical trial is to evaluate whether daily oral metformin extended-release (metformin-XR), taken prior to and in early pregnancy, can reduce the risk and severity of Hyperemesis Gravidarum (HG), a severe nausea and vomiting condition in pregnancy, in individuals…
Phase: PHASE1, PHASE2 • Sponsor: University of Southern California • Aim: Prevention
Last updated Jul 24, 2026 00:00 UTC
-
Heart attack breakthrough: drugs may beat stents for mild blockages
Disease control Recruiting nowThis study is a prospective, multicenter, open-label, non-inferiority, randomized controlled trial. A total of 2,000 patients with STEMI (\<24 hours or 7-14 days) or NSTEMI will be recruited from at least 20 centers in China. Eligible patients must have residual DS \< 70% at the …
Phase: NA • Sponsor: Harbin Medical University • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
New mRNA treatment targets Hard-to-Treat cancers in early trial
Disease control Recruiting nowThe goal of this phase 1 clinical trial is to evaluate the safety, tolerability, and preliminary antitumor activity of a peptide-delivered IL-22BP biotherapy in patients with advanced solid tumors. The main questions it aims to answer are: Is the IL-22BP formulation safe and tol…
Phase: PHASE1 • Sponsor: West China Hospital • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
ER study aims to replace CT scans with quick blood test for aortic emergencies
Diagnosis Not yet recruitingThe goal of this study is to evaluate the safety of integrating the Aortic Dissection Detection Risk Score (ADD-RS) and D-dimer testing for ruling out acute aortic syndrome (AAS) in the emergency department (ED). The main question it aims to answer: Can the combination of the ADD…
Sponsor: Chinese University of Hong Kong • Aim: Diagnosis
Last updated Jun 27, 2026 13:07 UTC
-
New drug aims to shrink polyps in inherited colon cancer condition
Disease control TerminatedThis open-label phase II trial tests how well TPST-1495 works in reducing the number of polyps in the small bowel and colon in patients with familial adenomatous polyposis (FAP). FAP is an inherited condition in which numerous polyps (growths that protrude from mucous membranes) …
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
Could a VR headset and ice pack replace painkillers after C-Section?
Symptom relief Not yet recruitingThis randomized controlled trial aims to evaluate the effectiveness of virtual reality and cryotherapy, used separately and in combination, in reducing postoperative pain and anxiety among women undergoing cesarean section under spinal anesthesia. Participants will be randomly as…
Phase: NA • Sponsor: Shahid Beheshti University of Medical Sciences • Aim: Symptom relief
Last updated Jul 16, 2026 00:00 UTC
-
Tape or zap: which helps kids with CP swallow better?
Disease control Not yet recruitingThe purpose of this study will be to compare the effect between kinesiotaping and neuromuscular electrical stimulation on dysphagia in children with bilateral spastic cerebral palsy.
Phase: NA • Sponsor: Beni-Suef University • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Keyhole brain surgery could spare children from shunt complications
Disease control Not yet recruitingEndoscopic third ventriculostomy in cases of hydrocephalus provide less invasive and safe technique than ventriculoperitoneal Shunt also decrease complications of ventriculoperitoneal Shunt
Phase: NA • Sponsor: Sohag University • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
Custom Stent-Graft aims to fix aortic aneurysms without open surgery
Disease control Recruiting nowThe purpose of this research is to assess safety and preliminary effectiveness of the Physician-Modified Terumo Treo Abdominal Stent-Graft System.
Phase: NA • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
Volunteers to be deliberately exposed to omicron in quest for better vaccines
Knowledge-focused Recruiting nowCOVHIC003 is a human infection challenge study in which healthy adults aged 18-50 previously vaccinated with an approved COVID-19 vaccine will be administered a SARS-CoV-2 Omicron EG.5.1 variant given by drops in the nose. The aim is to achieve breakthrough upper-respiratory infe…
Phase: PHASE1 • Sponsor: Imperial College London • Aim: Knowledge-focused
Last updated Jul 19, 2026 00:00 UTC
-
New COPD inhaler HSK39004 tested for Long-Term safety in 300 patients
Disease control Not yet recruitingThis clinical trial evaluates the long-term safety and efficacy of 3 mg HSK39004 Inhalation Suspension administered twice daily for 52 weeks in subjects aged 40 to 80 years with moderate-to-severe stable chronic obstructive pulmonary disease (COPD).
Phase: PHASE3 • Sponsor: Haisco Pharmaceutical Group Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC